Friday, February 28, 2020
(91outcomes.com) - The treatment-focused Gulf War Illness research program expires at the end of this fiscal year. The goal is to continue to grow this critically important treatment development research for the nearly one-third of Gulf War veterans debilitated by Gulf War Illness.
Tuesday, February 18, 2020
Wednesday, February 12, 2020
Updated February 12, 2020
New results from a GWIRP-funded brain-imaging study in Boston provide the first direct evidence of neuroinflammation in veterans with GWI. Based on early GWIRP-funded study results, a focus on identifying and confirming or denying the presence of persistent neuroinflammation in GWI has been a key GWIRP goal. These results provide the first objective evidence confirming the relevance of neuroinflammation in GWI and that treatments should indeed be targeted at countering this neuroinflammation.
Another key area of GWIRP-funded research has been related to role of the gut-brain axis in GWI. A GWIRP-funded study also from Boston and also just published assessed the relationships between GWI, GI symptoms, gut microbiome and inflammatory markers in GWV from the Boston Gulf War Illness Consortium (GWIC). Results showed